DMC1 and RAD51 bind FxxA and FxPP motifs of BRCA2 via two separate interfaces
Nucleic Acids Research · 08.07.2024 · 52 (12) · 7337-7353
DOI: 10.1093/nar/gkae452 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nucleic Acids Research, online erschienen am 03.06.2024. Verfasst von Simona Miron und 8 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Integrative Biology of the Cell (I2BC), Université Paris-Saclay, CEA, CNRS, Gif-sur-Yvette, France. Hauptthemen laut MEDLINE: Rad51 Recombinase, BRCA2 Protein, Cell Cycle Proteins, DNA-Binding Proteins. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 69 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: French Infrastructure for Integrated Structural Biology, European Community H2020, Institut National de la Santé et de la Recherche Médicale.
Abstract (Originalsprache)
In vertebrates, the BRCA2 protein is essential for meiotic and somatic homologous recombination due to its interaction with the RAD51 and DMC1 recombinases through FxxA and FxPP motifs (here named A- and P-motifs, respectively). The A-motifs present in the eight BRC repeats of BRCA2 compete with the A-motif of RAD51, which is responsible for its self-oligomerization. BRCs thus disrupt RAD51 nucleoprotein filaments in vitro. The role of the P-motifs is less studied. We recently found that deletion of Brca2 exons 12–14 encoding one of them (the prototypical ‘PhePP’ motif), disrupts DMC1 but not RAD51 function in mouse meiosis. Here we provide a mechanistic explanation for this phenotype by solving the crystal structure of the complex between a BRCA2 fragment containing the PhePP motif and DMC1. Our structure reveals that, despite sharing a conserved phenylalanine, the A- and P-motifs bind to distinct sites on the ATPase domain of the recombinases. The P-motif interacts with a site that is accessible in DMC1 octamers and nucleoprotein filaments. Moreover, we show that this interaction also involves the adjacent protomer and thus increases the stability of the DMC1 nucleoprotein filaments. We extend our analysis to other P-motifs from RAD51AP1 and FIGNL1.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Institute for Integrative Biology of the Cell (I2BC), Université Paris-Saclay, CEA, CNRS, Gif-sur-Yvette, France.
- Synchrotron SOLEIL, HelioBio group, L'Orme des Merisiers, Gif sur-Yvette, France.
- Genome Maintenance and Molecular Microscopy UMR 9019 CNRS, Université Paris-Saclay, Gustave Roussy, Villejuif, France.
- Department of Molecular Genetics, Erasmus MC Cancer Institute, Erasmus University Medical Center, 3000CA, Rotterdam, The Netherlands.
- Oncode Institute, Erasmus University Medical Center, 3000CA, Rotterdam, The Netherlands.
ORCID-Profile: Pierre Legrand, Pauline Dupaigne, Sophie Zinn-Justin, Alex N Zelensky
Förderung
- French Infrastructure for Integrated Structural Biology
- European Community H2020
- Institut National de la Santé et de la Recherche Médicale
- Erasmus Medical Center
- Dutch Cancer Society
- Josephine Nefkens Cancer Program
Zitieren
APA
Miron, S., Legrand, P., Dupaigne, P., van Rossum-Fikkert, S. E., Ristic, D., Majeed, A., Kanaar, R., Zinn-Justin, S., & Zelensky, A. N. (2024). DMC1 and RAD51 bind FxxA and FxPP motifs of BRCA2 via two separate interfaces. Nucleic Acids Research, 52(12), 7337-7353. https://doi.org/10.1093/nar/gkae452
Vancouver
Miron S, Legrand P, Dupaigne P, van Rossum-Fikkert SE, Ristic D, Majeed A, et al. DMC1 and RAD51 bind FxxA and FxPP motifs of BRCA2 via two separate interfaces. Nucleic Acids Research. 2024;52(12):7337-7353. doi:10.1093/nar/gkae452
BibTeX
@article{Miron2024,
author = {Miron, Simona and Legrand, Pierre and Dupaigne, Pauline and van Rossum-Fikkert, Sari E and Ristic, Dejan and Majeed, Atifa and Kanaar, Roland and Zinn-Justin, Sophie and Zelensky, Alex N},
title = {DMC1 and RAD51 bind FxxA and FxPP motifs of BRCA2 via two separate interfaces},
journal = {Nucleic Acids Research},
year = {2024},
volume = {52},
number = {12},
pages = {7337--7353},
doi = {10.1093/nar/gkae452}
}
EUVIMED